Ultramicrosize Griseofulvin
NDC 23155-864, Griseofulvin, tablet, from Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc.
- Product NDC
- 23155-864
- Status
- Listed
- Labeler
- Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA061996
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23155-864 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GRISEOFULVIN250 mg/1
Pharmacologic classes
Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23155-864-01 | 23155086401 | 100 TABLET in 1 BOTTLE, PLASTIC (23155-864-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ae369582-2e4c-48a4-ac42-0a77466654fdNADAC price for package 23155086401
GET /v1/drugs/nadac/23155086401
Use it
Look up 23155-864 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23155-864 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23155-864. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.